ArticleJAMA internal medicine2015

Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness-Reply.

Jean S Kutner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.